AB063. Potential synergistic effect by combination of PED-4 and PED-5 inhibitors plus theophylline in lung cancer?

BACKGROUND: Lung cancer remains the leading cause of cancer-related deaths worldwide and novel therapeutic approaches targeting crucial pathways are urgently needed to improve its treatment. Differentiation-based therapeutics (Methylxanthines) and phosphodiesterase inhibitors (type 4 and 5), have be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Domvri, Kalliopi, Hohenforst-Schmidt, Wolfgang, Zogas, Nikolaos, Petanidis, Savvas, Zarogoulidis, Paul, Porpodis, Konstantinos, Kioseoglou, Efi, Zarogoulidis, Konstantinos
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2016
Matèries:
Abstract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159351/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars